States seek reconsideration of new painkiller by FDA
12/12/2013 // West Palm Beach, Florida, US // JusticeNewsFlash // Justice News Flash // (press release)
U.S. – Twenty-eight states have asked the Food and Drug Administration to reconsider the approval of the new painkiller Zohydro. As reported by the Associated Press (AP), the state’s attorneys general assert that the narcotic pill’s approval could lead to a higher rate of prescription drug abuse, a problem that is of growing national concern.
Zohydro was approved by the FDA in October, and as noted by the AP, is the first single-ingredient hydrocodone drug to be cleared for patients in the United States. The pill is stated to be more potent than hydrocodone combination pills that are currently available on the market.
The letter sent to the FDA, which the agency has stated is currently being reviewed, is quoted as stating, “States attorneys general do not want a repeat of the recent past when potent prescription painkilling drugs entered the market without abuse-deterrent qualities and without clear guidance on how they were to be prescribed.”
This report is provided by Justice News Flash – U.S. Health News
Address: 215 South Olive Suite 300 W. Palm Beach FL 33401